Net income
−$24.2M
−61.7% vs same quarter last year
EPS, diluted
−$0.37
+2.6% vs same quarter last year
Operating cash flow
−$16.8M
−40.1% vs same quarter last year
Operating income
−$25.8M
−67.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$56M |
| FY24 | - | −$61M |
| FY23 | $0 | −$53.5M |
| FY22 | $317K | −$50.5M |
| FY21 | $2.1M | −$33.5M |
| FY20 | $2.3M | −$17M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | - | - | - |
| FY23 | - | - | - |
| FY22 | 50.1% | −16325.8% | −15937.3% |
| FY21 | 44.6% | −1629.2% | −1612.3% |
| FY20 | 44.6% | −739% | −737.2% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$45.5M |
| FY24 | −$55.1M |
| FY23 | −$49.3M |
| FY22 | −$44.8M |
| FY21 | −$30.9M |
| FY20 | −$14.7M |
| FY19 | - |
- Immuneering
- Healthcare median
Show the numbers
| Year | Immuneering | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | - | −58% |
| FY22 | −15937.3% | −80.4% |
| FY21 | −1612.3% | −71.8% |
| FY20 | −737.2% | −62.2% |
| FY19 | - | −46.2% |